<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for FOLD</title>
    <link />
    <description>Headlines for Amicus Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Amicus Therapeutics: The Good And The Bad</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1437011-amicus-therapeutics-the-good-and-the-bad.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 15 May 2013 13:31:30 GMT</pubDate>
    </item>
    <item>
      <title>Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Rally Insmed</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/insm/articles/186537/significant-near-term-top-line-data-catalyst-and-platform-technology-should-rally-insmed/2013-05-14.aspx?source=itxwebtxt0000015</link>
      <author>Trefis</author>
      <pubDate>Tue, 14 May 2013 10:39:21 GMT</pubDate>
    </item>
    <item>
      <title>Significant Near-Term Top-Line Data Catalyst And Platform Technology Should Propel Insmed</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431661-significant-near-term-top-line-data-catalyst-and-platform-technology-should-propel-insmed.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 14 May 2013 10:01:00 GMT</pubDate>
    </item>
    <item>
      <title>Amicus' CEO Discusses Q1 2013 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1422841-amicus-ceo-discusses-q1-2013-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 10 May 2013 00:46:06 GMT</pubDate>
    </item>
    <item>
      <title>Curing Parkinson's: The Alternative Approach - Is There Money To Be Made?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1320381-curing-parkinson-s-the-alternative-approach-is-there-money-to-be-made.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 04 Apr 2013 09:29:13 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1268891-amicus-therapeutics-ceo-discusses-q4-2012-results-earnings-call-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 12 Mar 2013 22:47:01 GMT</pubDate>
    </item>
    <item>
      <title>After-Hours Earnings Report for March 12, 2013 :  KW, DOLE, ACAD, GCA, GNMK, AVID, WSR, KTOS, GERN,</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/afterhours-earnings-report-for-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx-fold-gcap-cm226423.aspx?source=itxwebtxt0000015</link>
      <author>Nasdaq</author>
      <pubDate>Tue, 12 Mar 2013 14:00:05 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics Unveils Proprietary "CHART" Platform Technology</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3385437/amicus-therapeutics-unveils-proprietary-chart-platform-technology.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 04 Mar 2013 07:45:25 GMT</pubDate>
    </item>
    <item>
      <title>Don't Fold On Amicus Therapeutics Just Yet</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1225591-don-t-fold-on-amicus-therapeutics-just-yet.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 27 Feb 2013 14:28:39 GMT</pubDate>
    </item>
    <item>
      <title>Are These 3 Stocks Down for the Count?</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/19/are-these-3-stocks-down-for-the-count/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 19 Feb 2013 19:45:00 GMT</pubDate>
    </item>
    <item>
      <title>Amicus: Trial Detail Fails To Halt Share Slide</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1203871-amicus-trial-detail-fails-to-halt-share-slide.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 19 Feb 2013 15:12:05 GMT</pubDate>
    </item>
    <item>
      <title>A Legit Reason To Give Amicus' Fabry Drug Another Chance</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11844441/1/a-legit-reason-to-give-amicus-fabry-drug-another-chance.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 19 Feb 2013 06:30:00 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/16/this-week-in-biotech-15/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 16 Feb 2013 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Horrendous Health-Care Stocks This Week</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/15/3-horrendous-health-care-stocks-this-week-16/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 15 Feb 2013 20:36:00 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics' CEO Presents Lysosomal Disease Network WORLD Symposium Data Highlights Conferen</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1189151-amicus-therapeutics-ceo-presents-lysosomal-disease-network-world-symposium-data-highlights-conference-transcript.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 15 Feb 2013 17:15:01 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics Says Added 6-Month Results from Phase 3 Fabry Monotherapy Study Presented at LDN</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3338572/amicus-therapeutics-says-added-6-month-results-from-phase-3-fabry-monotherapy-stu.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 15 Feb 2013 10:32:32 GMT</pubDate>
    </item>
    <item>
      <title>Amicus Therapeutics Advances Chaperone-ERT Combo Platform in Pompe Diesease</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3333987/amicus-therapeutics-advances-chaperone-ert-combo-platform-in-pompe-diesease.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Thu, 14 Feb 2013 07:36:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks Under $10 Moving Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-biotech-stocks-under-10-moving-higher.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 12 Feb 2013 14:48:00 GMT</pubDate>
    </item>
    <item>
      <title>3 Biotech Stocks Under $10 Making Big Moves</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/3-biotech-stocks-under-10-making-big-moves.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Tue, 12 Feb 2013 14:43:00 GMT</pubDate>
    </item>
    <item>
      <title>Orphan Drug Mania: Amicus / Migalastat HCl</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1161571-orphan-drug-mania-amicus-migalastat-hcl.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 06 Feb 2013 15:23:47 GMT</pubDate>
    </item>
  </channel>
</rss>
